Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae , 2010 to 2014 [PDF]
Laura Mataseje+16 more
openalex +1 more source
Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]
Bucataru A+7 more
europepmc +1 more source
Treatment options for infections caused by carbapenem-resistantEnterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy? [PDF]
Federico Pérez+4 more
openalex +1 more source
Identification of Patients at Greatest Risk for Carbapenem Resistance in Patients With Serious Hospital-Onset Infections Due to Enterobacteriaceae Species [PDF]
Thomas P. Lodise+4 more
openalex +1 more source
Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae [PDF]
Matthias I. Gröschel+7 more
openalex +1 more source
The Prevalence of Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Clostridium difficile Infection in Canadian Hospitals. A Comparison of Survey Results. in 2010, 2012, and 2016. [PDF]
Philippe Martin+9 more
openalex +1 more source
High drug-pathogen mismatch in the management of invasive carbapenem-resistant Enterobacteriaceae infections at a tertiary hospital in Nigeria. [PDF]
Adekanmbi O+6 more
europepmc +1 more source